2006
Use of Cyclooxygenase Inhibitors and Risk of Melanoma in High‐Risk Patients
Ramirez C, Ma F, Federman D, Kirsner R. Use of Cyclooxygenase Inhibitors and Risk of Melanoma in High‐Risk Patients. Dermatologic Surgery 2006, 31: 748-753. DOI: 10.1111/j.1524-4725.2005.31703.Peer-Reviewed Original ResearchHigh-risk patientsRisk of melanomaCOX inhibitorsCyclooxygenase inhibitorOutcome measuresMiami Veterans Affairs Medical CenterVeterans Affairs Medical CenterChemoprevention of melanomaCOX inhibitor useCOX inhibitor usersNew melanoma diagnosisHigh-risk subjectsMetastasis of melanomaIndividual outcome measuresPrevious melanomaInhibitor usersInhibitor useRetrospective cohortMelanoma recurrenceNew melanomasResults EightyMelanoma incidenceMedical CenterTumor depthMelanoma metastases
1999
Skin cancer screening in primary care: Prevalence and barriers
Kirsner R, Muhkerjee S, Federman D. Skin cancer screening in primary care: Prevalence and barriers. Journal Of The American Academy Of Dermatology 1999, 41: 564-566. PMID: 10495376, DOI: 10.1016/s0190-9622(99)80053-x.Peer-Reviewed Original ResearchConceptsSkin cancer screeningPrimary care providersCancer screeningSkin cancerAdult patientsPrimary careCare providersSkin cancer screening practicesCancer screening practicesHigh-risk patientsPrimary care visitsHalf of physiciansPrimary care practitionersSkin cancer incidenceFrequent deterrentsCare visitsMortality benefitCancer incidenceScreening practicesPatient embarrassmentNew Haven CountyCare practitionersSuspect lesionsCounty Medical SocietyPhysicians' lack